Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02905357 · ClinicalTrials.gov registry record

Heart Attack Research Program- Imaging Study

A clinical trial of Myocardial Infarction, sponsored by NYU Langone Health.

Active
Registry status
450
Enrollment target
20
Study locations

NCT02905357 is a study of Myocardial Infarction that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 450 participants, below the 4,675-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (90% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02905357, a study of Myocardial Infarction, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
450 participants
Enrollment target
20
Study locations

Study Summary

The HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in patients with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant. Participants will be followed for recurrent clinical events, every 6 months, for a maximum of 10 years.

Conditions Studied

Myocardial Infarction

Interventions

  • DEVICE OCT
  • OTHER CMR

Study Locations (20)

California

  • Cedars-Sinai Medical Center - Los Angeles
  • UC San Diego Medical Center - San Diego
  • Stanford University - Stanford

New York

  • NYU Winthrop - Mineola
  • NYU Langone Medical Center - New York
  • Columbia University Medical Center/NYPH - New York

Pennsylvania

  • St. Luke's University Health Network - Bethlehem
  • University of Pittsburgh Medical Center - Pittsburgh

Alabama

  • University of Alabama-Birmingham - Birmingham

Florida

  • University of Florida Medical Center - Gainesville

Georgia

  • Emory University - Atlanta

Maryland

  • Johns Hopkins Medical Center - Baltimore

New Hampshire

  • Dartmouth-Hitchcock - Lebanon

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2016-09-12
Est. Completion 2027-06-30

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02905357

The ClinicalTrials.gov registry entry for NCT02905357 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,675-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (90% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 2 interventions - of which OCT is the first listed.

NCT02905357 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02905357 about?

NCT02905357 is a clinical study titled "Heart Attack Research Program- Imaging Study". The HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in patients with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant. Participants will be followed for recurrent clinical events, every ...

What is the current status of trial NCT02905357?

This trial is currently active not recruiting. The enrollment target is 450 participants. The study started on 2016-09-12. Estimated completion is 2027-06-30.

What conditions does trial NCT02905357 study?

This clinical trial studies the following conditions: Myocardial Infarction.

What interventions are being tested in trial NCT02905357?

The interventions under investigation include: OCT (DEVICE), CMR (OTHER).

Who is sponsoring clinical trial NCT02905357?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02905357 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myocardial Infarction

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.